Skip to main content
. 2016 Dec 15;10:2505–2513. doi: 10.2147/OPTH.S120803

Table 1.

Background information of interviewees’ institutions

All ophthalmologists University hospital ophthalmologists Nonacademic hospital ophthalmologists Clinic ophthalmologists
Number of ophthalmologists in the institution
≥11 6 6 0 0
6–10 3 0 2 1
1–5 9 1 5 3
Number of ophthalmologists trained for intravitreal injections
≥11 2 2 0 0
5–10 2 2 0 0
2–4 10 3 6 1
1 4 0 1 3
Institution size (bed count)
≥1,000 3 3 0 0
500–999 5 3 2 0
20–499 5 0 5 0
Unknown or ≤19 5 1 0 4
Payment method
DPCa 14 7 7 0
Non-DPC 4 0 0 4
Designated treatment location for anti-VEGF injections
Outpatient treatment rooms 7 5 1 1
Operating rooms 9 1 6 2
Both 2 1 0 1
Need to reserve space to perform anti-VEGF injections
Necessary 10 2 7 1
Unnecessary 8 5 0 3

Note:

a

An inpatient bundle payment system similar to the diagnosis-related groups used in Medicare in the US.

Abbreviations: anti-VEGF, anti-vascular endothelial growth factor; DPC, diagnosis procedure combination.